Alternatively, recent studies with a xenograft model of T47D human breast cancer cells expressing ER plus different PR isoforms demonstrated increased K6 mRNA expression in tumors in response to treatment with E + P that was dependent on the expression of PR [41]. The gene discussed is ESR1; the disease is breast cancer.